IUPAC Name: | 4-[[4-oxo-2-sulfanylidene-3-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazolidin-5-ylidene]methyl]benzoic acid |
Description: | CY-09 is a selective and direct NLRP3 inflammasome inhibitor which directly targeted NLRP3 itself. It directly binds to the ATP-binding motif of NLRP3 NACHT domain and inhibits NLRP3 ATPase activity, resulting in the suppression of NLRP3 inflammasome assembly and activation. |
Molecular Weight: | 423.43 |
Molecular Formula: | C19H12F3NO3S2 |
Canonical SMILES: | C1=CC(=CC(=C1)C(F)(F)F)CN2C(=O)C(=CC3=CC=C(C=C3)C(=O)O)SC2=S |
InChI: | InChI=1S/C19H12F3NO3S2/c20-19(21,22)14-3-1-2-12(8-14)10-23-16(24)15(28-18(23)27)9-11-4-6-13(7-5-11)17(25)26/h1-9H,10H2,(H,25,26)/b15-9- |
InChI Key: | DJTINRHPPGAPLD-DHDCSXOGSA-N |
Purity: | ≥ 98 % |
LogP: | 4.74290 |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Carbonyl Compounds
1-(5-Methoxy-1,3-benzoxazol-2-yl)piperidine-3-carboxylic acid
Customers Also Viewed
2-Methyl-2-propanyl [1,3-dihydroxy-2-(hydroxymethyl)-2-propanyl]carbamate
Copyright © 2025 BOC Sciences. All rights reserved.
Our Products